Revenue and Profit Growth
Sales growth of 2.1% in local currencies (like-for-like virtually stable); operating income up 3.8% in local currencies; EBITDA up 3.4% in local currencies; EBITDA margin stable at 15.5%.
Recurring Net Income and EPS
Recurring net income of EUR 3.3 billion; EPS increased 2.5% (6.4% in local currencies).
Strong Free Cash Flow and Cash Conversion
Generated EUR 3.8 billion free cash flow with a 58% cash conversion ratio (above target of 50%); net debt/EBITDA stable at 1.4x.
Construction Chemicals Momentum
Construction chemicals showed almost 16% sales growth in local currencies; integration of Cemix and FOSROC delivering ~11% organic sales growth with ~20% combined EBITDA margin; ambition to reach >EUR 9 billion sales by 2030 in construction chemicals.
Regional Outperformance in Asia & Latin America
Asia Pacific sales up 17% in local currencies (2.4% like-for-like) with record operating margin; India delivered double-digit growth and market share gains; Latin America up 13.5% in local currencies (6.9% like-for-like).
Portfolio Optimization and Shareholder Returns
Continued portfolio rotation (EUR 1.2 billion of sales rotated in 2025) with a target to rotate >20% of sales by 2030; returned EUR 1.5 billion to shareholders in 2025 and planning ~EUR 8 billion of buybacks/dividends 2026-2030 (approx. EUR 2bn buybacks + EUR 6bn dividends).
Operational Discipline and Margin Protection
Maintained stable operating margin despite negative currency impact; positive price/cost spread with disciplined pricing and cost actions (EBITDA margin held at 15.5% and operating margin broadly stable).
Working Capital and CapEx Discipline
Operating working capital at 11 days of sales (reduced 1 day year-on-year); CapEx around 4.5% of sales (guidance to remain stable), and 80% of growth CapEx allocated to high-growth markets.